Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations
{{output}}
Background: To review data from the pivotal phase III trials evaluating the efficacy and safety of direct oral anticoagulants (DOACs) versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF), ... ...
